Four 20 Pharma Gmbh (“Four 20”) a leading manufacturer, wholesaler, and importer of medical cannabis and medical devices, and Northern Green Canada Inc. (“NGC”) have completed their first successful shipment of non-irradiated medical cannabis flower. This shipment from Toronto, Canada to Paderborn, Germany is the part of a larger supply agreement between Four 20 and NGC that will extend into 2021. The shipped cannabis flower has been stringently tested, first in Canada for NGC by Eurofins, and subsequently, Four 20 commissioned an independent German laboratory to confirm the testing.

Mmp News Author, Medical Marijuana Program Connection, 09/17/2020 14:27:23

Open article: